Candel Therapeutics
United States
What IC360 knows, and how it knows it
This is a network record: collected from public sources with evidence kept per field. It has not been independently verified.
Verified facts
None yet. No field on this record has been independently verified.
Company-stated
Read from the company website itself.
- Company name
- Candel Therapeutics — Official company website
- Website
- candeltx.com — Official company website
Third-party reported
Reported by an outside source, not by the company.
- Country
- United States — Wikidata
Inferred by IC360
Derived by IC360 collection; treat as indicative.
- Company type
- Consultant — Assigned by IC360 collection from page content; the company did not state it
Not yet collected
No evidence has been gathered for these fields. They are left empty rather than guessed.
- City
- Industry
Leadership listed on the company website
MD Anderson Cancer Center
Director of the Parker Institute for Cancer Research
Candel Therapeutics · United States
South Florida Surgical Oncology
Medical Director
Candel Therapeutics · United States
Sue Stewart Pic
Chief Regulatory Officer
Candel Therapeutics · United States
Ileen Winick
Chief People Officer
Candel Therapeutics · United States
Mark Sims
Chief Commercial Officer
Candel Therapeutics · United States
Harvard Medical School
Chair, Department of Neurosurgery Brigham and Women’s Hospital and Professor
Candel Therapeutics · United States
Charles Schoch
Chief Financial Officer
Candel Therapeutics · United States
Memorial Sloan Kettering Cancer Center
Jerome and Nancy Kohlberg Emeritus Chair in Medicine
Candel Therapeutics · United States
Convergent Therapeutics
CEO and Co-Founder
Candel Therapeutics · United States
Paul B. Manning
Chair of the Board
Candel Therapeutics · United States
Paul Peter Tak
President & Chief Executive Officer
Candel Therapeutics · United States
Linked records in the network
Counts of records collected for this company. Individual people, products and facilities appear here once they pass their own public-eligibility rules.